Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fresenius Medical Care North America
Total 40 subjects will be randomized for participation into the study The subjects are Hemo-dialysis Dependent Chronic Kidney Disease (CKD) Stage 5D patients who are able to give informed consent to the study, and taking the phosphate binder sevelamer carbonate tablets.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subjects ≥18 years of age able to give written informed consent to the study
